Research Article

[Retracted] Analysis of the Clinical Efficacy of Azacytidine + Venetoclax in the Treatment of Elderly Patients with Relapsed Refractory Acute Myeloid Leukemia

Table 1

General information.

ItemTreatment group (n = 10)Control group (n = 10)χ 2/t

Gender0.2020.653
 Male5 (50%)6 (60%)
 Female5 (40%)4 (40%)
Age (years old)70.21 ± 8.3970.44 ± 7.610.0640.949

Classification0.4000.940
 M02 (20%)2 (20%)
 M23 30%)3 (30%)
 M43 (30%)2 (20%)
 M52 (20%)3 (30%)